Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: J Allergy Clin Immunol. 2014 Jan;133(1):27–33. doi: 10.1016/j.jaci.2013.10.026

Table 1.

Challenges with Studies Evaluating Cross-Age Response to Asthma Treatment

Issue Example(s)
Recruitment · Need for culturally diverse recruitment materials
· Need for Age-appropriate recruitment strategies
Consent/Assent · Requirement of parental/guardian consent for minors
· Incorporation of Assent procedures for children
Intervention Selection · Difficulty in maintaining consistency of intervention therapy due to differences in dosing and drug availability
Control Selection · Limitations in the use of placebo controls for children
Outcome Measurement · Dependence on proxy reporting of outcomes for children
· Dearth of cross-age instruments to measure quality of life, asthma control, symptoms and exacerbations
Participant Growth & Development · Need to account for physical growth (e.g., weight, height) of pediatric participants
Physical Limitations in Data Collection · Physical and developmental limits for testing and data collection (e.g., phlebotomy, spirometry, sputum induction)
· Increased safety restrictions in testing of children (e.g., methacholine bronchoprovocation)
Consideration of Long-term Effects · Careful monitoring and follow-up for long term developmental effects in children
Reporting of Results · Determination of how data across ages will be subdivided (e.g., age cut-offs, including adolescents as adults or children)